Discovery could, among other things, slash the numbers of false negatives in PSA tests. Xiaohu Xia and his team, including researchers from Louisiana State University and the University of Texas at Dallas, have developed a new catalyst that could make lab tests like the PSA much more sensitive. Read the article.
A cheap test which can gauge the size of prostate cancer tumours has the potential to save thousands of lives each year, scientists believe The new test, which works like a pregnancy test, is twice as reliable as the current PSA blood test and would allow patients to find out in minutes whether they had cancer based on the levels of EN2 in their urine – a protein which is produced by tumours. Read the article.
Men who have an orgasm a day are lowering their risk of developing prostate cancer. A study has revealed that those men who ejaculate more often during their lifetime have a 22% lower risk of getting the disease. The study doesn’t give any reasons why the practice of ejaculation may help to stave off prostate cancer, but there are theories which have been made public previously. It has been thought that ejaculation can rid the prostate of cancer-causing chemicals, while there are also theories that if sperm is ‘cleaned out’ in this manner it can stop a build-up of old …
Men receiving active surveillance were 24 times more likely to die from causes other than prostate cancer over 15 years. Caucasian men with favorable-risk prostate cancer who opt for active surveillance have a low risk of progression to lethal cancer for a decade after diagnosis, according to researchers. Read the article.
New research has revealed that five different types of prostate cancer exist. World renowned robotic prostate cancer surgeon, Dr. David Samadi says this discovery may change the outlook of prostate cancer screening. “Discovering five different types of the disease could change how they’re distinguished from one another and may even mean different treatments for each, targeted to the individual patient,” said Dr. Samadi, Chairman of Urology and Chief of Robotic Surgery at Lenox Hill Hospital in New York City. Read the article.
Scientists at the UW Carbone Cancer Center are in human trial phase for a vaccine to treat aggressive forms of prostate cancer. Scientists say this vaccine, combined with another drug, will help the body target prostate cancer cells. “We believe this vaccine has the potential to train a patient who has prostate cancer, to train their immune system to recognize the tumors that are growing as foreign and to begin to clear them and remove them from the body,” said Dr. Richard Lesniewski, the president and CEO of Madison Vaccines. Read the article.
Awareness: The PCCN-Toronto and Side by Side Prostate Cancer Support Groups Newsletter. In this Issue: Dr. Morton at our July Scotiabank Awareness Night Dr. Kell at our May Scotiabank Awareness Night Do It For Dads – the 2015 Father’s Day Walk/Run – with photos Ask the Doctor – Dr. Hamilton on PET scans Feedback from your Board of Directors Annual Volunteer Dinner Tell us what you think – take our website based survey 2015 Scotiabank Awareness Nights Schedule Read it by clicking the link below to open the pdf file: Sept_2015_Newsletter